ANNALES DE DERMATOLOGIE ET DE VENEREOLOGIE

Journal website Submission website

Note: The following journal information is for reference only. Please check the journal website for updated information prior to submission.

Journal Title

ANN DERMATOL VENER

ISSN / eISSN

0151-9638

Aims and Scope

Les Annales de dermatologie sont le rendez-vous mensuel incontournable de toute la dermatologie francophone, grâce à leur comité de rédaction qui assure une sélection rigoureuse des articles selon les normes de l'édition scientifique internationale.
Une revue didactique, véritable aide à la pratique médicale quotidienne
Pour compléter et enrichir la partie scientifique, la rubrique Formation médicale continue propose aux lecteurs des textes didactiques et interactifs (Cas pour diagnostic, Notes de pharmacovigilance, la Question du praticien, Dermatologie chirurgicale, la Sélection bibliographique du mois...) qui les font bénéficier d'une formation post-universitaire diversifiée et de qualité. La revue consacre également un espace pour la publication de questions des lecteurs auxquelles des experts apportent une réponse.

Subject Area

DERMATOLOGY

CiteScore

1.10

View Trend

CiteScore Ranking

Category	Quartile	Rank
Medicine - Dermatology	Q3	#93/133

Web of Science Core Collection

Science Citation Index Expanded (SCIE)	Social Sciences Citation Index (SSCI)
Indexed	-

Category (Journal Citation Reports 2023)	Quartile
DERMATOLOGY - SCIE	Q4

H-index

Country/Area of Publication

FRANCE

Publisher

Elsevier Masson

Publication Frequency

Monthly

Year Publication Started

1977

Annual Article Volume

Open Access

Contact

MASSON EDITEUR, 21 STREET CAMILLE DESMOULINS, ISSY, MOULINEAUX CEDEX 9, FRANCE, 92789

Popular journals in the same field
Recent articles

A rare and severe lichenoid skin eruption after apalutamide treatment for prostate cancer: (2023) P.-F. Guglielmini, C. Massone, C. Grasso, A. Francese, M. Vincenti, S. Chiodi, M. Rossi, A. Maconi

A survey of patients with facial angiofibromas associated with tuberous sclerosis complex: Short-, medium- and long-term efficacy and safety of topical rapamycin: (2023) N. Sigg, J. Fouquet, D. Morin, D. Farges, S. Vrignaud, L. Martin

Nivolumab-induced eosinophilic fasciitis: An unusual immune-related adverse event that needs to be recognized by practitioners: (2023) M. Benzaquen, L. Christ, N. Sutter, B.C. Özdemir

Evaluation of parents’ knowledge following a sun-protection campaign in schools in La Reunion: (2023) N. Breton, L. Bruneau, J. Dumez, J. Miquel, F. Villeroy, M. Beylot-Barry, N. Sultan-Bichat, A. Bertolotti

Self-induced nail disorders (SINDs): What do we know so far?: (2023) M. Starace, S. Cedirian, A. Alessandrini, F. Bruni, B.M. Piraccini, M. Iorizzo

Predictors of initial incomplete resection of basal cell carcinoma of the face and neck: (2023) M. Borg, F. Amatore, J.-M. Foletti, B. Bertrand, N. Macagno, E. Delaporte, M.-A. Richard

Clinical characteristics, initial treatment, and prognosis of mycosis fungoides and Sézary syndrome: A retrospective, single-center study at the Centre Hospitalier Universitaire of Quebec: (2023) M. Lachance, M.-M. Thibeault

Omalizumab-induced paradoxical urticaria responsive to dupilumab: (2023) A.-C. Fougerousse, A. Badaoui

Cutaneous mucormycosis in an immunosuppressed patient: (2023) M. Boileau, G. Escure, S. Azib, F. Dezoteux

Hidradenitis suppurativa: Influence of hormonal factors on disease activity in women in France: (2023) A.-C. Fougerousse, Z. Reguiai, F. Maccari, P. Guillem, J.-L. Perrot

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started